Literature DB >> 24483245

The balance of intestinal Foxp3+ regulatory T cells and Th17 cells and its biological significance.

Xiaofei Shen1, Junfeng Du, Wenxian Guan, Yong Zhao.   

Abstract

Balanced mucosal immunity in the gut is critical for host homeostasis and defense. Th17 cells are a subset of IL-17-producing CD4+ T cells, which play a crucial role in clearing pathogens during host defense reactions and in inducing tissue inflammation in autoimmune diseases. CD4+CD25+ Foxp3+ regulatory T cells (Tregs) are recognized as one of the major regulatory factors in immune tolerance and inflammatory responses. Since both Tregs and Th17 cells pertain to the gut immune system, their inter-regulation and balance represent a novel mechanism for maintaining the intestinal immune and inflammatory homeostasis. Accordingly, the imbalance and dysregulation of Tregs and Th17 cells in the intestine is closely associated with intestinal autoimmune disorders like the inflammatory bowel diseases. In this review, we discuss the characteristics of gut Tregs and Th17 cells and their role in gut diseases.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24483245     DOI: 10.1586/1744666X.2014.882232

Source DB:  PubMed          Journal:  Expert Rev Clin Immunol        ISSN: 1744-666X            Impact factor:   4.473


  9 in total

1.  Changes in the cytokine expression of peripheral Treg and Th17 cells in children with rotavirus enteritis.

Authors:  Huaifu Dong; Sehua Qu; Xin Chen; Hongwei Zhu; Xiaoyan Tai; Jiahua Pan
Journal:  Exp Ther Med       Date:  2015-05-22       Impact factor: 2.447

2.  Stereotypic Expansion of T Regulatory and Th17 Cells during Infancy Is Disrupted by HIV Exposure and Gut Epithelial Damage.

Authors:  Sonwabile Dzanibe; Katie Lennard; Agano Kiravu; Melanie S S Seabrook; Berenice Alinde; Susan P Holmes; Catherine A Blish; Heather B Jaspan; Clive M Gray
Journal:  J Immunol       Date:  2021-11-24       Impact factor: 5.422

3.  Citrate Attenuates Adenine-Induced Chronic Renal Failure in Rats by Modulating the Th17/Treg Cell Balance.

Authors:  Yan Ou; Shuiqin Li; Xiaojing Zhu; Baosong Gui; Ganglian Yao; Liqun Ma; Dan Zhu; Rongguo Fu; Heng Ge; Li Wang; Lining Jia; Lifang Tian; Zhaoyang Duan
Journal:  Inflammation       Date:  2016-02       Impact factor: 4.092

4.  Donor-Specific Regulatory T Cells Acquired from Tolerant Mice Bearing Cardiac Allograft Promote Mixed Chimerism and Prolong Intestinal Allograft Survival.

Authors:  Xiao-Fei Shen; Jin-Peng Jiang; Jian-Jun Yang; Wei-Zhong Wang; Wen-Xian Guan; Jun-Feng Du
Journal:  Front Immunol       Date:  2016-11-17       Impact factor: 7.561

5.  Mucosal Immunity Related to FOXP3+ Regulatory T Cells, Th17 Cells and Cytokines in Pediatric Inflammatory Bowel Disease.

Authors:  Jinhee Cho; Sorina Kim; Da Hee Yang; Juyeon Lee; Kyeong Won Park; Junyong Go; Chang-Lim Hyun; Youngheun Jee; Ki Soo Kang
Journal:  J Korean Med Sci       Date:  2018-12-10       Impact factor: 2.153

6.  Kuijieling-Containing Serum Regulates Th17 and Treg Cell Differentiation by Inhibiting STAT3 Signaling In Vitro.

Authors:  Yu Long; Yuqing He; Fengming Jie; Sixin Li; Yanli Wu; Yanwu Li; Qun Du
Journal:  Evid Based Complement Alternat Med       Date:  2019-08-25       Impact factor: 2.629

7.  Exploiting the Zonulin Mouse Model to Establish the Role of Primary Impaired Gut Barrier Function on Microbiota Composition and Immune Profiles.

Authors:  Alba Miranda-Ribera; Maria Ennamorati; Gloria Serena; Murat Cetinbas; Jinggang Lan; Ruslan I Sadreyev; Nitya Jain; Alessio Fasano; Maria Fiorentino
Journal:  Front Immunol       Date:  2019-09-19       Impact factor: 7.561

Review 8.  Opportunities to Target T Cell Trafficking in Pediatric Inflammatory Bowel Disease.

Authors:  Eirini Giannoudaki; Siobhan Gargan; Seamus Hussey; Aideen Long; Patrick T Walsh
Journal:  Front Pediatr       Date:  2021-03-18       Impact factor: 3.418

Review 9.  Antibiotics and the Human Gut Microbiome: Dysbioses and Accumulation of Resistances.

Authors:  M P Francino
Journal:  Front Microbiol       Date:  2016-01-12       Impact factor: 5.640

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.